The diagnosis and management of asymptomatic primary hyperparathyroidism revisited

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 2, 2009, Pages 333-334

  Khan, Aliya A ^a   Bilezikian, John P ^b   Potts Jr , John T ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b Columbia University ^*  (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; PATHOGENESIS; PATIENT MONITORING; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL;

EID: 59749083094     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1757     Document Type: Conference Paper

References (5)

1. Heath 3rd H, Hodgson SF, Kennedy MA 1980 Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 302:189-193
2. Bilezikian JP 2007 Primary hyperparathyroidism. In: DeGroot L, ed.; Arnold A, section editor. www.ENDOTEXT.org (January 1, 2007 version). South Dartmouth, MA: MDTEXT.COM, Inc.
3. 1991 Proceedings of the Consensus Development Conference on the Management of Asymptomatic Primary Hyperparathyroidism. J Bone Miner Res Suppl 2:S1-S124
4. Bilezikian JP, Potts JT, Fuleihan Gel-H, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2-N11, and J Clin Endocrinol Metab 87:5353-5361
5. Bilezikian JP, Khan AA, Potts JT 2009 Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94:335-339